Health Condition 1: H533- Other and unspecified disorders ofbinocular vision
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Participants in the age group of 18-35 years Participants with the BCVA 6/6, N6. Participants with Asthenopic symptoms. Participants of either gender Participants who provide consent form and are willing to be part of the study
Exclusion criteria
Exclusion criteria: Participants with known cases of ocular pathologies inclusive of surface disorder Participants with binocular vision anomalies due to constant strabismus, amblyopia, and anisometropia more than 2.00 Diopters Participants with NSBV (Nonstrabismic binocular vision) anomalies on treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Mean difference in Visual Discomfort Questionnaire and Binocular Vision Dysfunction Questionnaire total scores pre- and post-optometric intervention. 2.Reduction in severity of symptoms related to Internal Symptom Factor 3.Prevalence and type of Symptom Factor Contributing to visual discomfortTimepoint: 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Change in visual attention, reading rate and accuracy parameters before and after intervention. 2.Changes in binocular vision parameters. 3.Association between:Visual Discomfort Questionnaire, Binocular Vision Dysfunction Questionnaire scores and clinical binocular vision findings. 4.Association between Visual discomfort severity and reading/attention performance. 5.Differential improvement in individual symptoms related to the Internal Symptom Factor. Timepoint: 12 weeks | — |
Countries
India
Contacts
MGM Institute of Health Sciences